Abstract
In maple syrup urine disease (MSUD), branched-chain L-amino (BCAA) and 2-oxo acids (BCOA) accumulate in body fluids owing to an inherited deficiency of branched-chain 2-oxo acid dehydrogenase complex activity. In MSUD, little information is available on the significance of urinary disposal of branched-chain compounds. We examined the renal clearance of leucine, valine, isoleucine and alloisoleucine, and their corresponding 2-oxo acids 4-methyl-2-oxopentanoate (KIC), 3-methyl-2-oxobutanoate (KIV), (S)- (S-KMV), and (R)-3-methyl-2-oxopentanoate (R-KMV), using pairs of plasma and urine samples (n=63) from 10 patients with classical MSUD. The fractional renal excretion of free BCAA was in the normal range (<0.5%) and indepen-dent of the plasma concentrations. The excretion of bound (N-acylated) BCAA was normal and not significantly dependent on the BCAA plasma concentrations. The fractional renal excretion of BCOA was in the order KIC≪KIV<R-KMV≤S-KMV (range (%): KIC 0.1–25; KIV 0.14–21.3; S-KMV 0.26–24.6; R-KMV 0.1–35.9), significantly correlated with the KIC plasma concentrations, and generally higher than that of the related BCAA. The results show that the renal excretion of free BCAA as well as of the acylated derivatives is negligible. The renal excretion of BCOA, however, to some extent counteracts increases in BCAA concentrations and thus contributes to the lowering of total BCAA pools in MSUD.
Similar content being viewed by others
References
Brodehl J, Gellissen K, Jäkel A (1968) Endogenous renal transport of free amino acids in infancy and childhood. Pediatrics 42: 395-404.
Chuang DT, Shih VE (1995) Disorders of branched chain amino acid and keto acid metabolism. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1239-1278.
Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
Dancis J, Levitz M, Westall RG (1960) Maple syrup urine disease: branched-chain ketoaciduria. Pediatrics 25: 72-79.
Fernho. PM, Lubitz D, Danner DJ, et al (1985) Thiamine response in maple syrup urine disease. Pediatr Res 19: 1011-1016.
Ghazali S, Barrat TM (1974) Urinary excretion of calcium and magnesium in children. Arch Dis Child 49: 97-101.
Hagenfeld L, Naglo AS (1987) New conjugated urinary metabolites in intermediate type of maple syrup disease. Clin Chim Acta 169: 77-84.
Hayashi T, Tsuchiya H, Naruse H (1983) The stabilization of a-keto acids in biological samples using hydrazide gel column treatment. Clin Chim Acta 132: 321-325.
Hill RL (1965) Hydrolysis of proteins. Adv Protein Chem 20: 37-107.
Hoffer LJ, Taveroff A, Robitaille L, Mamer OA, Reimer MLJ (1993) α-Keto and α-hydroxy branched-chain acid interrelationship in normal humans. J Nutr 123: 1513-1521.
Jakobs C, Solem E, Ek J, Halvorsen K, Jellum E (1977) Investigation of the metabolic pattern in maple syrup urine disease by means of glass capillary gas chromatography and mass spectrometry. J Chromatogr 143: 31-38.
Kampmann J, Siersbaek-Nielsen K, Kristensen M, Hansen M (1974) Rapid evaluation of creatinine clearance. Acta Med Scand 196: 517-520.
Lancaster G, Mamer OA, Scriver CR (1974) Branched-chain alpha-keto acids isolated as oxime derivatives: relationship to the corresponding hydroxy acids and amino acids in maple syrup urine disease. Metabolism 23: 257-265.
Langenbeck U (1984) Pathobiochemical and pathophysiological analysis of the MSUD phenotype. In Adibi SA, Fekl W, Langenbeck U, Schauder P, eds. Branched Chain Amino and Keto Acids in Health and Disease. Basel: S Karger, 315-334.
Langenbeck U, Wendel U, Mench-Hoinowski A, et al (1978) Correlations between branchedchain amino acids and branched-chain a-keto acids in blood in maple syrup urine disease. Clin Chim Acta 88: 283-291.
Langenbeck U, Wendel U, Luthe H (1979) Renal clearance of branched-chain 2-oxo acids in maple syrup urine disease. J Clin Chem Clin Biochem 17: 176.
Lehnert W, Werle E (1988) Elevated excretion of N-acetylated branched-chain amino acids in maple syrup urine disease. Clin Chim Acta 172: 123-126.
Livesey G, Edwards WTE (1985) Quantification of branched-chain α-keto acids as quinoxalinols: importance of excluding oxygen during derivatization. J Chromatogr 337: 98-102.
Menkes JH (1959) Maple syrup urine disease. Isolation and identification of organic acids in the urine. Pediatrics 23: 348-353.
Poole RC, Halestrap AP (1993) Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol 264: C761-C782.
Price NT, Jackson VN, Halestrap AP (1998) Cloning and sequencing of four mammalian monocarboxylate transporter (MCT) homologues conforms the existence of a transporter family with an ancient past. Biochem J 329: 321-328.
Rossi R, Danzebrink S, Linnebürger K, et al (1994) Assessment of tubular reabsorption of sodium, glucose, phosphate and amino acids based on spot urine samples. Acta Paediatr 83: 1282-1286.
Schadewaldt P, Hummel W, Trautvetter U, Wendel U (1989) A convenient enzymatic method for the determination of 4-methyl-2-oxopentanoate: comparison with high performance liquid chromatographic analysis. Clin Chim Acta 183: 171-182.
Schadewaldt P, Hammen H-W, Dalle-Feste C, Wendel U (1990) On the mechanism of Lalloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease. J Inher Metab Dis 13: 137-150.
Schadewaldt P, Wendel U, Hammen H-W (1996) Determination of R-and S-3-methyl-2-oxopentanoate enantiomers in human plasma: suitable method for label enrichment analysis. J Chromatogr B 682: 209-218.
Schadewaldt P, Bodner A, Hammen H-W, Wendel U (1998) Assessment of whole body L-leucine oxidation by non-invasive L-[13C]leucine breath tests: a reappraisal in maple syrup urine disease patients, obligate heterozygotes, and healthy subjects. Pediatr Res 43: 592-600.
Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259-263.
Shigematsu Y, Kikuchi K, Momoi T, et al (1983) Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease. J Inher Metab Dis 6: 183-189.
Snyderman SE, Goldstein F, Sansariq C, Norton PM (1984) The relationship between the branched chain amino acids and their α-ketoacids in maple syrup urine disease. Pediatr Res 18: 851-853.
Steiner RW (1984) Interpreting the fractional excretion of sodium. Am J Med 77: 699-702.
Thompson GN, Bresson JL, Pacy PJ, et al (1990a) Protein and leucine metabolism in maple syrup urine disease. Am J Physiol 258: E654-E660.
Thompson GN, Chalmers RA, Halliday D (1990b) The contribution of protein catabolism to metabolic decompensation in 3-hydroxy-3-methylglutaric aciduria. Eur J Pediatr 149: 346-350.
Thompson GN, Walter JH, Leonard JV, Halliday D (1990c) In vivo enzyme activity in inborn errors of metabolism. Metabolism 39: 799-807.
Thompson GN, Francis DEM, Halliday D (1991) Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management. J Pediatr 119: 35-41.
Treacy E, Clow CL, Reade TR, Chitayat D, Mamer OA, Scriver CR (1992) Maple syrup urine disease: interrelations between branched-chain amino, oxo-and hydroxyacids; implications for treatment, associations with CNS demyelination. J Inher Metab Dis 15: 121-135.
Wahlefeld AW, Siedel J (1985) Creatine and creatinine. In Bergmeyer HU, ed. Methods in Enzymatic Analysis, vol VII. Weinheim: Verlag Chemie, 488-506.
Wendel U, Even G, Langenbeck U, Schadewaldt P, Hummel W (1992) Determination of (S)-and (R)-2-oxo-3-methylvaleric acid in plasma of patients with maple syrup urine disease. Clin Chim Acta 208: 85-91.
Yu Y-M, Young VR, Castillo L, et al (1995) Plasma arginine and leucine kinetics and urea production rates in burn patients. Metabolism 44: 659-666.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schadewaldt, P., Hammen>, HW., Ott, AC. et al. Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease. J Inherit Metab Dis 22, 706–722 (1999). https://doi.org/10.1023/A:1005540016376
Issue Date:
DOI: https://doi.org/10.1023/A:1005540016376